Goldman Sachs Upgrades Anacor Pharma To Buy On 'De-Risked' Story
July 21, 2015 at 07:15 AM EDT
In a report published Tuesday, Goldman Sachs analyst Gary Nachman upgraded the rating on Anacor Pharmaceuticals Inc (NASDAQ: ANAC) from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.